Chemokine expression in murine experimental allergic encephalomyelitis

Journal of Neuroimmunology
R GodiskaP W Gray

Abstract

Chemokines are a family of low molecular mass proteins with chemotactic and cell activating activities. Reverse transcription-polymerase chain reaction and Northern hybridization were used to examine their expression during murine experimental allergic encephalomyelitis (EAE), an autoimmune disease used as a model of multiple sclerosis. The mRNAs encoding RANTES, MIP-1 alpha, MIP-1 beta, TCA3 (I-309), IP-10, JE (MCP-1), KC (MGSA/gro), and MARC (MCP-3) were induced in the spinal cord 1-2 days before clinical signs were apparent. SDF, a cDNA predicted to encode a chemokine-like product, was expressed in normal as well as diseased spinal cords. No expression of C10 or MIP-2 was detected. Activated encephalitogenic T cells expressed message for RANTES, MIP-1 alpha, MIP-1 beta, and TCA3. These results define a subset of chemokines that may play an important role in the inflammatory process during murine EAE.

References

Jan 1, 1991·Annual Review of Immunology·J J OppenheimK Matsushima
May 1, 1989·Journal of Neuroimmunology·D N BourdetteH Offner
Jan 1, 1987·The Journal of Immunology : Official Journal of the American Association of Immunologists·J SatohT Tabira
Aug 23, 1984·Nature·G H WongJ W Schrader
Mar 1, 1994·Immunology Today·M Baggiolini, C A Dahinden
Apr 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R M RansohoffV K Tuohy

❮ Previous
Next ❯

Citations

Nov 30, 2000·Current Infectious Disease Reports·K A Cassady, R J Whitley
Sep 10, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tamir Ben-Hur
Aug 1, 1996·Trends in Neurosciences·J E Merrill, E N Benveniste
Jun 1, 1996·Cytokine & Growth Factor Reviews·R M RansohoffM Tani
Nov 12, 2003·Cytokine·Mehrnaz Gharaee-KermaniSem H Phan
Dec 4, 2003·Journal of Neuroimmunology·Güher Saruhan-DireskeneliPiraye Serdaroğlu
Feb 25, 2000·European Journal of Pharmacology·M LiangR Horuk
Jan 22, 2003·Journal of Immunological Methods·Daniele D'AmbrosioFrancesco Sinigaglia
May 26, 1998·Journal of the Neurological Sciences·B G Xiao, H Link
Sep 1, 1996·Molecular Immunology·P VanguriC M Chi
Oct 12, 2000·Journal of Neuroimmunology·B C KieseierH P Hartung
Jun 5, 2002·Journal of Neuroimmunology·Torben L SørensenFinn Sellebjerg
Sep 27, 2003·Journal of Neuroimmunology·Sana EltayebAnders Ericsson-Dahlstrand
Jul 30, 1999·Journal of Neuroimmunology·R M Ransohoff
Apr 29, 1998·Trends in Neurosciences·R M Ransohoff, M Tani
Sep 11, 1999·Trends in Neurosciences·R J Miller, O Meucci
Mar 25, 2000·Neurochemistry International·Y L LeeL F Eng
Jan 23, 1998·Human Immunology·B H BennettsG J Stewart
Jan 1, 1997·Trends in Microbiology·T E Lane, M J Buchmeier
May 3, 2003·Methods : a Companion to Methods in Enzymology·William J KarpusKevin J Kennedy
Jun 6, 2012·Cell Research·Changsheng Du, Xin Xie
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T L SørensenR M Ransohoff
Dec 12, 2002·Journal of Neurovirology·Necat HavliogluJane Y Wu
Sep 1, 1996·The Journal of Experimental Medicine·C C BleulT A Springer
Oct 4, 2000·The Journal of Experimental Medicine·L IziksonA D Luster
Oct 3, 2001·The Journal of Experimental Medicine·J L McQualterC C Bernard
Mar 19, 2008·The Journal of Experimental Medicine·Thaddeus CarlsonBenjamin Segal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.